Restrictive Legends and Stop-Transfer Orders Clause Example from Business Contracts

This example Restrictive Legends and Stop-Transfer Orders clause appears in 25 contracts from 23 companies

Restrictive Legends and Stop-Transfer Orders. (a) Legends. Participant understands and agrees that the Company shall cause the legends set forth below or legends substantially equivalent thereto, to be placed upon any certificate(s) evidencing ownership of the Shares together with any other legends that may be required by the Company or by state or federal securities laws: THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE "ACT") AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR ...HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR, IN THE OPINION OF COUNSEL SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE THEREWITH. THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER AND A RIGHT OF FIRST REFUSAL HELD BY THE ISSUER OR ITS ASSIGNEE(S) AS SET FORTH IN THE EXERCISE NOTICE BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER. SUCH TRANSFER RESTRICTIONS AND RIGHT OF FIRST REFUSAL ARE BINDING ON TRANSFEREES OF THESE SHARES. THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER FOR A PERIOD OF TIME FOLLOWING THE EFFECTIVE DATE OF THE UNDERWRITTEN PUBLIC OFFERING OF THE COMPANY'S SECURITIES SET FORTH IN AN AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES AND MAY NOT BE SOLD OR OTHERWISE DISPOSED OF BY THE HOLDER PRIOR TO THE EXPIRATION OF SUCH PERIOD WITHOUT THE CONSENT OF THE COMPANY OR THE MANAGING UNDERWRITER. (b) Stop-Transfer Notices. Participant agrees that, in order to ensure compliance with the restrictions referred to herein, the Company may issue appropriate "stop transfer" instructions to its transfer agent, if any, and that, if the Company transfers its own securities, it may make appropriate notations to the same effect in its own records. (c) Refusal to Transfer. The Company shall not be required (i) to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Exercise Notice, or (ii) to treat as owner of such Shares or to accord the right to vote or pay dividends to any purchaser or other transferee to whom such Shares shall have been so transferred. -3- 8. Successors and Assigns. The Company may assign any of its rights under this Exercise Notice to single or multiple assignees, and this Exercise Notice shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, this Exercise Notice shall be binding upon Participant and his or her heirs, executors, administrators, successors and assigns. View More

Found in MINERVA SURGICAL INC contract

CASTLE BIOSCIENCES INC Contracts

Forms of Stock Option Agreement, Exercise Notice and Investment Representation Statement under the 2008 Stock Plan (Filed With SEC on June 26, 2019)

Peloton Therapeutics, Inc. Contracts

2010 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on April 26, 2019)

Satsuma Pharmaceuticals, Inc. Contracts

Form of Stock Option Agreement under 2016 Equity Incentive Plan (Filed With SEC on August 16, 2019)

Applied Molecular Transport Inc. Contracts

2016 Equity Incentive Plan and forms of agreement thereunder (Filed With SEC on May 18, 2020)

Nkarta, Inc. Contracts

Form of Stock Option Agreement for 2015 Equity Incentive Plan (Filed With SEC on June 19, 2020)

PMV Pharmaceuticals, Inc. Contracts

2013 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on September 4, 2020)

2013 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on September 21, 2020)

Kinnate Biopharma Inc. Contracts

2018 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on November 13, 2020)

Roblox Corp Contracts

Amended and Restated 2017 Equity Incentive Plan, as amended, and related form agreements (Filed With SEC on January 8, 2021)

Akoya Biosciences, Inc. Contracts

Akoya Biosciences, Inc. 2015 Equity Incentive Plan, as amended, and form of stock option agreement thereunder (Filed With SEC on March 26, 2021)

Nalu Medical, Inc. Contracts

Forms of Award Agreement under the 2014 Equity Incentive Plan, as amended (Filed With SEC on July 9, 2021)

MINERVA SURGICAL INC Contracts

2008 Stock Plan, as amended, and related form agreements (Filed With SEC on September 27, 2021)

ARTELO BIOSCIENCES, INC. Contracts

Form of Stock Option Agreement2018 Equity Incentive Plan (Filed With SEC on September 27, 2018)

Unity Biotechnology, Inc. Contracts

Form of Stock Option Agreement under 2013 Equity Incentive Plan (Filed With SEC on April 5, 2018)

Kezar Life Sciences, Inc. Contracts

Form of Stock Option Agreement under the 2015 Equity Incentive Plan (Filed With SEC on May 24, 2018)

Phunware, Inc. Contracts

Phunware, Inc. 2009 Equity Incentive Plan, including form agreements under the 2009 Equity Incentive Plan (Filed With SEC on April 11, 2018)

IMPINJ INC Contracts

IMPINJ, INC. 2010 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on June 2, 2016)

CareDx, Inc. Contracts

CAREDX, INC. 2008EQUITY INCENTIVE PLAN (Filed With SEC on June 3, 2014)

IMMUMETRIX, INC. 2013EQUITY INCENTIVE PLAN (Filed With SEC on June 3, 2014)

YODLEE INC Contracts

YODLEE, INC. 2009EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on June 30, 2014)

Sunrun Inc. Contracts

SUNRUN INC. 2013EQUITY INCENTIVE PLAN (as amended and restated as of March 20, 2014) (Filed With SEC on June 25, 2015)

Juno Therapeutics, Inc. Contracts

JUNO THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on November 17, 2014)

Ovid Therapeutics Inc. Contracts

OVID THERAPEUTICS INC. 2014 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on April 10, 2017)

Sienna Biopharmaceuticals, Inc. Contracts

SIENNA BIOPHARMACEUTICALS, INC. (F/K/A SIENNA LABS, INC.) 2010 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on July 3, 2017)

Inogen, Inc. Contracts

INOGEN, INC. 2012EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on November 27, 2013)